Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice
about
Control of adult neurogenesis by programmed cell death in the mammalian brainAllopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's diseaseEnvironmental modulations of the number of midbrain dopamine neurons in adult miceAllopregnanolone and neurogenesis in the nigrostriatal tract.Finding degrees of separation: experimental approaches for astroglial and oligodendroglial cell isolation and genetic targetingPhysical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner.Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells.Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey modelDifferences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans.Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice.Dopamine and adult neurogenesis.Death in the substantia nigra: a motor tragedy.Therapeutic potentials of human embryonic stem cells in Parkinson's diseaseInflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disordersEnvironmental and behavioral modulation of the number of substantia nigra dopamine neurons in adult mice.Stem cell-derived dopamine neurons for brain repair in Parkinson's disease.Cellular repair strategies in Parkinson's disease.Programmed cell death during postnatal development of the rodent nervous system.Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?New perspectives in stem cell research: beyond embryonic stem cells.Neurogenesis in Neurotoxin-induced Animal Models for Parkinson's Disease-A Review of the Current Status.Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.Development and aging of a brain neural stem cell niche.Can Valproic Acid Regulate Neurogenesis from Nestin+ Cells in the Adult Midbrain?Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.Targeting Cdk5 activity in neuronal degeneration and regeneration.Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture.Biomaterial microenvironments to support the generation of new neurons in the adult brain.Functional repertoire of interleukin-6 in the central nervous system - a review.Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
P2860
Q26751456-1B520D84-DAF4-4CD1-B10A-8E768C2BE49DQ27334826-216E52EE-A80E-4247-9E4F-B029017CE6B2Q28468524-CF526E11-2DDB-4BB6-A0EC-88CCBAA0166FQ34033021-882D3F0A-A0D1-4C73-9F7C-B41BF6268410Q34224054-39FC849B-2BAA-443C-B649-79A9875EA5F8Q34461436-49E7F76C-B44F-4A6B-8608-250277A3D9B9Q34660649-AB9AFF99-268B-4EB7-BAEA-B61FC82D757FQ34749390-625D6FFC-85F3-4E00-9FC8-3398FF3C746EQ36080085-391ED645-0CA4-49A4-9540-870792FB6639Q36334459-E6F6D0B1-F4AE-4B2B-AC3E-A4468AAD3D29Q36652288-58FE6B70-EA5F-4EF8-8C14-544C4D5A1A29Q36847262-DE7C3C50-F60A-4CCB-A781-C22C88F3C215Q37131248-244E5417-1BC5-412B-9DEE-3983D9F42B2DQ37254517-ACDEA235-0986-4CD1-8338-7F6FCDA37D3DQ37403681-CD398024-CA79-43BF-8177-F12052A2365FQ37704372-0783FDD5-6BE6-4C17-9DB7-61C5B182AB17Q37823336-6B2D2983-4CCE-4F57-8C93-BE5AC8283C5BQ37845409-4A75DF67-FB62-49B8-A3B5-1553C20521F4Q37857754-92733A44-1A93-43EA-91AD-CDB4C2B6AC2AQ37863714-61866017-5F38-4766-B3B6-6A26F4C673BBQ37978305-24EE5214-D13A-4082-A96F-9B2AA8DBA4BAQ38950746-BA0735B9-B6BA-4C83-BE63-5E327A8103D1Q39014810-10CC98A5-7C03-4575-B76B-93CAF779A984Q39156635-F9E048C2-C0F8-4447-B68B-7E3EC678581BQ39257825-D37E18F2-EB79-43EF-9F66-763F4DBFCBF7Q41720010-0ADC752A-3102-40E0-BF40-B8DC670446B3Q41812452-91C610EE-F1DA-4D65-B723-2441BBC9FC75Q42241977-081D9EE9-E09D-49F7-944F-1A5A7035F244Q47440251-D76C549B-F5B9-4720-A65A-B7028DA1EEF9Q48518649-262A1A76-392D-4064-9BB2-B8B2E368D44B
P2860
Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@ast
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@en
type
label
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@ast
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@en
prefLabel
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@ast
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@en
P2093
P2860
P921
P1433
P1476
Enhanced de novo neurogenesis ...... Parkinson's disease-like mice
@en
P2093
Lindsey Lien
Liying Chi
Michael Bishop
Xiaoyang Shan
Zheng Zhang
P2860
P304
P356
10.1634/STEMCELLS.2005-0487
P577
2006-01-19T00:00:00Z